Anti-fibrotic effect of iguratimod on pulmonary fibrosis by inhibiting the fibroblast-to-myofibroblast transition

Lin, HB; Wu, CC; Zhu, F; Zhang, GF; Xie, YS; Cui, Y; Dong, GF; Zhang, X

Zhang, X (corresponding author), Guangdong Prov Peoples Hosp, Dept Rheumatol, 58 Zhongshan Rd 2, Guangzhou 510080, Guangdong, Peoples R China.; Zhang, X (corresponding author), Guangdong Acad Med Sci, Dept Rheumatol, 58 Zhongshan Rd 2, Guangzhou 510080, Guangdong, Peoples R China.

ADVANCES IN MEDICAL SCIENCES, 2020; 65 (2): 338

Abstract

Purpose: Pulmonary fibrosis (PF) is a severe lung disease causing significant morbidity and mortality. PF pathogenesis is attributed to the fibroblast......

Full Text Link